Author: Mehta, Meenu; Deeksha; Tewari, Devesh; Gupta, Gaurav; Awasthi, Rajendra; Singh, Harjeet; Pandey, Parijat; Chellappan, Dinesh Kumar; Wadhwa, Ridhima; Collet, Trudi; Hansbro, Philip M.; Kumar, S Rajesh; Thangavelu, Lakshmi; Negi, Poonam; Dua, Kamal; Satija, Saurabh
Title: Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases Cord-id: ekgdsv4f Document date: 2019_8_1
ID: ekgdsv4f
Snippet: Oligonucleotide-based therapies are advanced novel interventions used in the management of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These agents primarily act by gene silencing or RNA interference. Better methodologies and techniques are the need of the hour that can deliver these agents to tissues and cells in a target specific manner by which their maximum potential can be reached in the management of chronic inflammatory diseases. Nanoparti
Document: Oligonucleotide-based therapies are advanced novel interventions used in the management of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These agents primarily act by gene silencing or RNA interference. Better methodologies and techniques are the need of the hour that can deliver these agents to tissues and cells in a target specific manner by which their maximum potential can be reached in the management of chronic inflammatory diseases. Nanoparticles play an important role in the target-specific delivery of drugs. In addition, oligonucleotides also are extensively used for gene transfer in the form of polymeric, liposomal and inorganic carrier materials. Therefore, the current review focuses on various novel dosage forms like nanoparticles, liposomes that can be used efficiently for the delivery of various oligonucleotides such as siRNA and miRNA. We also discuss the future perspectives and targets for oligonucleotides in the management of respiratory diseases.
Search related documents:
Co phrase search for related documents- acid amplification and acute respiratory disease cause: 1
- acid amplification and acute sars cov respiratory syndrome cov: 1, 2, 3
- acid amplification and lung alveolar: 1, 2
- acid amplification and lung tissue: 1
- acid chain and action mechanism: 1, 2
- acid chain and acute respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acid chain and acute sars cov respiratory syndrome cov: 1, 2, 3
- acid chain and lung disease: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date